報價延遲最少15分鐘:2025/07/16 07:55 EDT
盤前時段
|
||||
|
12.79 
|
|
|
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.94/0.50
|
|
企業價值
759.23M
|
| 資產負債 |
|
每股賬面淨值
0.75
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
23.61M
|
|
每股收益
0.30
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
報價延遲最少15分鐘：2025/07/16 07:55 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community. |
